Splenic marginal zone lymphoma: a population-based study on the 2001–2008 incidence and survival in the United States

References

• Arcaini L, Paulli M. Splenic marginal zone lymphoma: hydra with many heads? Haematologica 2010;95:534–537.
   PubMed Web of Science ®Google Scholar
• Franco V, Florena AM, Iannitto E. Splenic marginal zone lymphoma. Blood 2003;101:2464–2472.
   PubMed Web of Science ®Google Scholar
• Harris N, Jaffe E, Vardiman J, et al. WHO classification of tumors of haematopoietic and lymphoid tissues: introduction. Tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2001. pp 12–13.
   Google Scholar
• Matutes E, Oscier D, Montalban C, et al. Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria. Leukemia 2008;22:487–495.
   PubMed Web of Science ®Google Scholar
• Zucca E, Bertoni F, Roggero E, et al. Management of rare forms of lymphoma. Curr Opin Oncol 1998;10:377–384.
   PubMedGoogle Scholar
• Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol 1998;16:2780–2795.
   PubMed Web of Science ®Google Scholar
• A clinical evaluation of the International lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 1997;89:3909–3918.
   PubMed Web of Science ®Google Scholar
• Mausner JS, Kramer S. Mausner and Bahn epidemiology. Philadelphia: WB Saunders; 1985.
   Google Scholar
• Brown CC. The statistical comparison of relative survival rates. Biometrics 1983;39:941–948.
   PubMed Web of Science ®Google Scholar
• Berger F, Felman P, Thieblemont C, et al. Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients. Blood 2000;95:1950–1956.
   PubMed Web of Science ®Google Scholar
• Arcaini L, Lazzarino M, Colombo N, et al. Splenic marginal zone lymphoma: a prognostic model for clinical use. Blood 2006;107:4643–4649.
   PubMed Web of Science ®Google Scholar
• Szynglarewicz B, Matkowski R, Smorag Z, et al. Hepatitis C virus infection and locally advanced splenic marginal zone lymphoma. Pathol Oncol Res 2007;13:382–384.
   PubMed Web of Science ®Google Scholar
• Gurvits GE, Mahtani R, Halperin I. Hepatitis C virus and splenic marginal zone lymphoma with villous lymphocytes: away from conventional therapy. Scand J Gastroenterol 2007;42:1392–1393.
   PubMed Web of Science ®Google Scholar
• Pitini V, Arrigo C, Righi M, et al. Systematic screening for HCV infection should be performed in patients with splenic marginal zone lymphoma. Br J Haematol 2004;124:252–253.
   PubMed Web of Science ®Google Scholar
• Moccia F, Tognoni E, Boccaccio P. The relationship between splenic marginal zone B-cell lymphoma and chronic liver disease associated with hepatitis C virus infection. Ann Ital Med Int 1999;14:288–293.
   PubMedGoogle Scholar
• Chuang SS, Liao YL, Chang ST, et al. Hepatitis C virus infection is significantly associated with malignant lymphoma in Taiwan, particularly with nodal and splenic marginal zone lymphomas. J Clin Pathol 2010;63:595–598.
   PubMed Web of Science ®Google Scholar
• Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556–562.
   PubMed Web of Science ®Google Scholar
• Armstrong GL, Wasley A, Simard EP, et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006;144:705–714.
   PubMed Web of Science ®Google Scholar
• Zuckerman E, Zuckerman T. Hepatitis C and B-cell lymphoma: the hemato-hepatologist linkage. Blood Rev 2002;16:119–125.
   PubMed Web of Science ®Google Scholar
• Voinchet H, Etienne G, Ghiringelli CB, et al. [Splenic marginal zone lymphoma and autoimmunity: report of six cases]. Rev Med Interne 2010;31:4–11.
   PubMed Web of Science ®Google Scholar
• Ziakas PD, Giannouli S, Tasidou A, et al. Multiple autoimmune phenomena in splenic marginal zone lymphoma. Leuk Lymphoma 2006;47:772–775.
   PubMed Web of Science ®Google Scholar
• Pettersson T, Pukkala E, Teppo L, et al. Increased risk of cancer in patients with systemic lupus erythematosus. Ann Rheum Dis 1992;51:437–439.
   PubMed Web of Science ®Google Scholar
• Fries JF. Epidemiology of cancer in rheumatoid arthritis: methodologic pitfalls. Am J Med 1985;78:12–14.
   PubMed Web of Science ®Google Scholar
• Kassan SS, Thomas TL, Moutsopoulos HM, et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978;89:888–892.
   PubMed Web of Science ®Google Scholar
• Baro C, Salido M, Espinet B, et al. New chromosomal alterations in a series of 23 splenic marginal zone lymphoma patients revealed by Spectral Karyotyping (SKY). Leuk Res 2008;32:727–736.
   PubMed Web of Science ®Google Scholar
• Remstein ED, Law M, Mollejo M, et al. The prevalence of IG translocations and 7q32 deletions in splenic marginal zone lymphoma. Leukemia 2008;22:1268–1272.
   PubMed Web of Science ®Google Scholar
• Mateo M, Mollejo M, Villuendas R, et al. 7q31–32 allelic loss is a frequent finding in splenic marginal zone lymphoma. Am J Pathol 1999;154:1583–1589.
   PubMed Web of Science ®Google Scholar
• Baseggio L, Traverse-Glehen A, Callet-Bauchu E, et al. Relevance of a scoring system including CD11c expression in the identification of splenic diffuse red pulp small B-cell lymphoma (SRPL). Hematol Oncol 2011;29:47–51.
   PubMed Web of Science ®Google Scholar
• Robledo C, Garcia JL, Benito R, et al. Molecular characterization of the region 7q22.1 in splenic marginal zone lymphomas. PLoS One 2011;6:e24939.
   PubMed Web of Science ®Google Scholar
• Traverse-Glehen A, Baseggio L, Salles G, et al. Splenic marginal zone B-cell lymphoma: a distinct clinicopathological and molecular entity. Recent advances in ontogeny and classification. Curr Opin Oncol 2011;23:441–448.
   PubMed Web of Science ®Google Scholar
• Salido M, Baró C, Oscier D, et al. Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group. Blood 2010;116:1479–1488.
   PubMed Web of Science ®Google Scholar
• Morton LM, Wang SS, Devesa SS, et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood 2006;107:265–276.
   PubMed Web of Science ®Google Scholar
• Boren E, Gershwin ME. Inflamm-aging: autoimmunity, and the immune-risk phenotype. Autoimmun Rev 2004;3:401–406.
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860–867.
   PubMed Web of Science ®Google Scholar